SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction

Eur Heart J. 2023 Oct 12;44(38):3931. doi: 10.1093/eurheartj/ehad404.

Authors

Harald Sourij¹, Faisal Aziz¹, Harald Mangge², Dirk von Lewinski³

Affiliations

¹ Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
² Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
³ Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

PMID: 37350395
DOI: 10.1093/eurheartj/ehad404

No abstract available

Publication types

Comment

MeSH terms

Humans
Inflammation
Myocardial Infarction* / complications
Myocardial Infarction* / drug therapy
Sodium-Glucose Transporter 2

Substances

Sodium-Glucose Transporter 2